UK markets closed

Biogen Inc. (BIIB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
231.69-2.15 (-0.92%)
At close: 04:00PM EDT
233.00 +1.31 (+0.57%)
After hours: 07:40PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 33.73B
Enterprise value 39.61B
Trailing P/E 28.96
Forward P/E 14.93
PEG ratio (5-yr expected) 6.24
Price/sales (ttm)3.50
Price/book (mrq)2.22
Enterprise value/revenue 4.10
Enterprise value/EBITDA 18.80

Trading information

Stock price history

Beta (5Y monthly) -0.02
52-week change 3-21.14%
S&P500 52-week change 323.76%
52-week high 3298.73
52-week low 3189.44
50-day moving average 3216.46
200-day moving average 3235.63

Share statistics

Avg vol (3-month) 31.15M
Avg vol (10-day) 3966.64k
Shares outstanding 5145.6M
Implied shares outstanding 6145.6M
Float 8145.09M
% held by insiders 10.16%
% held by institutions 193.18%
Shares short (15 May 2024) 43.48M
Short ratio (15 May 2024) 42.6
Short % of float (15 May 2024) 42.69%
Short % of shares outstanding (15 May 2024) 42.39%
Shares short (prior month 15 Apr 2024) 43.26M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 23:1
Last split date 318 Jan 2001

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024


Profit margin 12.07%
Operating margin (ttm)27.28%

Management effectiveness

Return on assets (ttm)4.86%
Return on equity (ttm)8.05%

Income statement

Revenue (ttm)9.66B
Revenue per share (ttm)66.69
Quarterly revenue growth (yoy)-7.00%
Gross profit (ttm)N/A
Net income avi to common (ttm)1.17B
Diluted EPS (ttm)7.99
Quarterly earnings growth (yoy)1.40%

Balance sheet

Total cash (mrq)1.07B
Total cash per share (mrq)7.38
Total debt (mrq)6.95B
Total debt/equity (mrq)45.66%
Current ratio (mrq)2.10
Book value per share (mrq)104.49

Cash flow statement

Operating cash flow (ttm)1.65B
Levered free cash flow (ttm)899.92M